U.S. Markets closed

Aimmune Therapeutics: 2Q Earnings Snapshot

BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Thursday reported a loss of $62.9 million in its second quarter.

On a per-share basis, the Brisbane, California-based company said it had a loss of $1.01.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 93 cents per share.

Aimmune Therapeutics shares have dropped 19% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.34, a decline of 35% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AIMT at https://www.zacks.com/ap/AIMT